Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux
AimsSUMOylation is a post-translational modification that plays a crucial role in the cellular stress response. We aimed to demonstrate whether and how the SUMO E2 conjugation enzyme Ubc9 affects acute myocardial ischemic (MI) injury.Methods and ...
Qing Xiao, Yi Quan, Jiandong Luo
exaly +3 more sources
Background Hepatic ischaemia/reperfusion (I/R) injury poses a common clinical dilemma encountered during liver transplantation (LT), characterised by substantial cellular death and inflammation reactions.
Kang Huang +8 more
doaj +2 more sources
microRNA-214-Mediated UBC9 Expression in Glioma [PDF]
It has been reported that ubiquitin-conjugating enzyme 9 (Ubc9),the unique enzyme2 in the sumoylation pathway, is up-regulatedin many cancers. However, the expression and regulation ofUBC9 in glioma remains unknown.
Xiaochao Tan, Boqin Qiang, Jiangang Yuan
exaly +1 more source
Is Transthyretin a Regulator of Ubc9 SUMOylation? [PDF]
Ageing and mutations of transthyretin (TTR), the thyroid hormones and retinol transporting protein lead to amyloidosis by destabilizing the structure of TTR.
Elżbieta Wieczorek +6 more
doaj +1 more source
Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. [PDF]
Increasing evidence has pointed to an important role of SUMOylation in cell cycle regulation, especially for M phase. In the current studies, we have obtained evidence through in vitro studies that the master M phase regulator CDK1/cyclin B kinase ...
Yee-Fun Su +4 more
doaj +1 more source
Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway. [PDF]
UBC9, the only known E2-conjugating enzyme involved in SUMOylation, is a key regulator in fibrosis. However, the roles of UBC9 in liver fibrosis remain unclear.
Sufen Fang +6 more
doaj +1 more source
The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer
Functional loss of E-cadherin is frequent during tumor progression and occurs through a variety of mechanisms, including proteolytic cleavage. E-cadherin downregulation leads to the conversion of a more malignant phenotype promoting Epithelial to ...
Maria Elisa Sabatini +11 more
doaj +1 more source
Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways. [PDF]
Canonical ubiquitin-like proteins (UBLs) such as ubiquitin, Sumo, NEDD8, and ISG15 are ligated to targets by E1-E2-E3 multienzyme cascades. The Sumo cascade, conserved among all eukaryotes, regulates numerous biological processes including protein ...
Jing Wang +7 more
doaj +1 more source
Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells. [PDF]
UBC9 encodes a protein that conjugates small ubiquitin-related modifier (SUMO) to target proteins thereby changing their functions. Recently, it was noted that UBC9 expression and activity play a role in breast tumorigenesis and response to anticancer ...
Shibo Ying +3 more
doaj +1 more source
Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.
UBC9, the sole E2-conjugating enzyme required for SUMOylation, is a key regulator of essential cellular functions and, as such, is frequently altered in cancers. Along these lines, we recently reported that its expression gradually increases during early
Domenico Mattoscio +14 more
doaj +1 more source

